How to acquire, integrate, and scale independent optometry practices into a high-value multi-location platform in the fragmented $18B U.S. optometry market
Find Optometry Practice Acquisition TargetsThe U.S. optometry market is one of the most attractive consolidation opportunities in lower middle market healthcare. With tens of thousands of independent practices generating $1M–$4M in annual revenue, the sector is highly fragmented, recession-resistant, and structurally supported by an aging population and rising myopia rates. Most of these practices are owned by solo optometrists aged 55–70 who lack a clear succession plan, creating a steady pipeline of motivated sellers. A well-executed roll-up strategy allows a buyer — whether an individual operator, a regional group, or a PE-backed platform — to acquire practices at 3–5.5x EBITDA individually and exit the consolidated platform at a meaningful multiple expansion, often 7–10x EBITDA, by demonstrating scale, recurring revenue, and reduced key-person risk.
Optometry is an ideal roll-up industry for several compounding reasons. First, demand is structurally non-cyclical: patients need annual or biennial eye exams regardless of economic conditions, and contact lens subscriptions create predictable recurring revenue streams. Second, the market is extraordinarily fragmented — the top vision care platforms control a small fraction of total practices, leaving vast white space for regional consolidators. Third, the seller demographic is highly favorable: a large cohort of retiring ODs in their late 50s and 60s are actively seeking liquidity, yet many have not engaged a broker or begun succession planning, allowing buyers to source deals off-market at favorable terms. Fourth, optical retail dispensaries attached to practices generate 40–60% gross margins on frames and lenses, providing a high-margin revenue layer that pure medical practices lack. Finally, SBA 7(a) financing is widely available for individual acquisitions, enabling a buyer to build a platform with disciplined use of leverage before pursuing institutional capital.
The core roll-up thesis in optometry rests on acquiring independent practices at single-asset multiples of 3–5.5x EBITDA, centralizing administrative overhead, standardizing clinical and optical retail operations, and exiting the consolidated group at a premium multiple of 7–10x EBITDA reflecting enterprise scale and reduced risk. Each acquired practice contributes a stable, recurring patient panel of 2,000–5,000 active patients with high recall return rates, creating a diversified revenue base that is far less dependent on any single OD or payer contract than a solo practice. Value is created through four mechanisms: margin expansion via group purchasing power on frames, lenses, and equipment; revenue growth through cross-location recall programs, contact lens subscription capture, and ancillary services such as myopia management and dry eye clinics; talent leverage by deploying associate ODs across locations to reduce key-person dependency; and multiple arbitrage between entry and exit valuations. The most successful optometry roll-ups focus on a defined geographic footprint — typically a metro area or regional market — to maximize operational synergies and brand recognition while maintaining the community trust that drives patient loyalty.
$800K–$3.5M annual revenue per location
Revenue Range
$200K–$900K EBITDA per location at 20–35% margins
EBITDA Range
Establish the Platform Practice
Acquire or designate a flagship practice with $1.5M–$3.5M in revenue and strong operational infrastructure to serve as the management and integration hub. This location should have an experienced office manager, at least one associate OD already in place, and a healthy optical dispensary. The platform acquisition sets the template for clinical protocols, billing systems, practice management software, and optical retail merchandising that all future add-ons will adopt. Prioritize practices with clean financials, a transferable lease, and a seller willing to remain for 24–36 months.
Key focus: Select a flagship with existing associate coverage and management depth to absorb integration work without disrupting patient care
Source Add-On Targets Off-Market
Build a proprietary deal pipeline by systematically reaching out to independent ODs in your target geography through state optometry association directories, AOA member lists, local CE event networking, and direct mail campaigns to practices meeting your revenue and demographic criteria. Off-market sourcing consistently yields better pricing and more motivated sellers than broker-listed practices. Target ODs aged 58–68 in solo practices with no associate, as these owners face the clearest succession gap. Aim to maintain 8–12 active conversations at any time to ensure consistent deal flow without overpaying on any single transaction.
Key focus: Prioritize direct outreach to retiring solo ODs in your target metro who have not yet engaged a broker or listed their practice
Structure Each Add-On for Risk Mitigation
Structure each add-on acquisition as an asset purchase to avoid assuming unknown liabilities, with the seller financing 10–20% of the purchase price via a subordinated seller note tied to a 2–3 year transition employment agreement. Require the selling OD to remain as an employed associate through the transition, with compensation structured around collections to align incentives. Negotiate non-compete and non-solicitation agreements covering a minimum 5-mile radius and 3-year term. Use SBA 7(a) financing for the majority of each transaction in the early stages of the roll-up before transitioning to institutional credit facilities as the platform reaches $5M+ in aggregate EBITDA.
Key focus: Tie seller notes and earn-outs to patient retention metrics at 12 and 24 months post-close to protect against patient attrition risk
Integrate Operations and Centralize Administration
Post-close, migrate each acquired practice onto the platform's practice management system — typically Eyefinity, RevolutionEHR, or Compumed — within 90 days. Centralize billing, insurance credentialing, accounts payable, and HR functions at the platform level to eliminate redundant overhead and capture 300–600 basis points of margin improvement per acquired location. Standardize the optical dispensary frame board with group-negotiated lab contracts and wholesale pricing from key suppliers. Implement a unified recall and reactivation program across all locations to capture lapsed patients and drive same-store revenue growth of 5–10% annually.
Key focus: Standardize practice management software and centralize billing within 90 days of each acquisition to capture administrative synergies quickly
Drive Organic Growth Through Ancillary Services
Once two or more locations are integrated, layer in high-margin ancillary revenue streams that individual practices often lack the scale to offer profitably. Myopia management programs using orthokeratology or MiSight lenses command $1,500–$3,000 per patient annually and are underserved in most independent practices. Dry eye clinics using LipiFlow or iLux generate $800–$2,000 per treatment and face minimal insurance reimbursement headwinds. Specialty contact lens fitting for keratoconus and post-surgical patients adds premium revenue with limited incremental cost. These services increase revenue per patient encounter, differentiate the platform from corporate optical chains, and improve patient retention by deepening clinical relationships.
Key focus: Identify which ancillary service lines have unmet local demand and can be deployed across multiple locations using shared equipment and cross-referral protocols
Prepare the Platform for Institutional Exit
Beginning 18–24 months before a targeted exit, shift focus to EBITDA quality and story-ready financials. Engage a quality of earnings firm to validate adjusted EBITDA, normalize owner compensation across locations, and document all add-backs. Ensure all insurance contracts are properly assigned or re-credentialed under the platform entity. Confirm that no single location represents more than 30% of consolidated revenue. Reduce key-person risk at each site by ensuring at least one associate OD is in place and patient relationships are distributed across the clinical team. Prepare a growth narrative demonstrating same-store revenue trends, successful integrations, and a pipeline of additional acquisition targets to maximize exit valuation.
Key focus: Target a consolidated platform of 5–10 locations with $5M–$15M in aggregate revenue and $1.5M–$4M in EBITDA before engaging PE buyers or strategic acquirers
Group Purchasing Power on Optical Inventory and Lab Services
Consolidated platforms can negotiate frame and lens pricing 15–25% below what independent practices pay individually, dramatically improving optical dispensary margins. Partnering with two or three preferred optical labs and consolidating frame vendor relationships from the typical 8–12 vendors per practice down to 3–4 across the group reduces cost of goods and simplifies inventory management. These savings flow directly to EBITDA without requiring revenue growth.
Centralized Billing and Insurance Credentialing
Independent optometry practices frequently leave 5–10% of collectible revenue on the table through inconsistent coding, slow credentialing of new ODs, and inadequate denial management. Centralizing billing under a dedicated revenue cycle management function — either in-house or outsourced to a healthcare-focused RCM vendor — improves net collections rates, accelerates cash flow, and enables systematic renegotiation of reimbursement rates as the platform's patient volume increases across multiple payer contracts.
Recall and Reactivation Program Standardization
Many independent practices have recall systems that are inconsistently executed, relying on a single front-desk staff member sending postcards. Deploying a platform-wide automated recall system — using tools like Weave, Solutionreach, or Demandforce — that sends multi-channel reminders via text, email, and phone can increase annual recall return rates from 55–60% to 70–75% across the portfolio. A 10-percentage-point improvement in recall rates at a practice with 3,000 active patients represents 300 additional exam appointments annually, adding $150K–$240K in incremental revenue per location.
Associate OD Deployment and Capacity Expansion
Many acquired solo practices are operating at or near capacity under a single OD seeing 20–24 patients per day. Adding an associate optometrist at a location with excess scheduling capacity — particularly practices with strong patient panels but limited hours — can increase revenue by $300K–$600K per year per associate while the platform absorbs recruiting, credentialing, and onboarding costs efficiently across multiple sites. Associate deployment also reduces key-person risk, which is one of the primary valuation discounts applied to solo practices by acquirers.
Optical Retail Revenue Mix Optimization
Optical dispensary revenue typically represents 40–55% of a well-run optometry practice's total revenue and carries gross margins of 50–65% on frames and lenses. Many acquired practices underperform in optical retail due to outdated frame inventory, undertrained opticians, or a cultural reluctance by the selling OD to focus on retail sales. Implementing consistent optical sales training, modernizing frame boards with high-demand brands, and introducing premium lens upsell protocols can increase capture rate — the percentage of patients who purchase eyewear in-house — from 50–60% to 70–80%, significantly increasing revenue per patient encounter without adding clinical capacity.
Multiple Arbitrage Between Individual and Platform Valuations
Individual optometry practices in the $1M–$3M revenue range typically transact at 3–5.5x EBITDA in the lower middle market. A consolidated platform of 6–10 locations with $8M–$15M in revenue and demonstrable systems, management depth, and growth trajectory commands 7–10x EBITDA from PE buyers and strategic acquirers seeking established vision care platforms. This spread — often 3–5 turns of EBITDA — is the engine of roll-up economics, creating enterprise value from operational integration and scale rather than solely from organic growth.
The primary exit path for an optometry roll-up platform is a sale to a private equity-backed vision care consolidator or a larger regional eye care group seeking to expand its geographic footprint. Buyers at this level — including platforms backed by PE sponsors focused on healthcare services — typically pay 7–10x EBITDA for platforms with $5M–$15M in revenue, clean financials, diversified payer mix, and demonstrated ability to integrate acquisitions. A secondary exit path is a recapitalization with a PE sponsor where the operator retains 20–40% equity and rolls into a larger vehicle, capturing a second liquidity event when the PE sponsor ultimately exits. For operators targeting a clean sale, the ideal timeline is 5–7 years from platform formation to exit, with the final 18–24 months dedicated to EBITDA normalization, quality of earnings preparation, and pipeline documentation. Operators should engage an investment banker with specific healthcare services M&A experience — not a generalist business broker — at least 12 months before a targeted transaction to position the platform competitively and run a disciplined sell-side process.
Find Optometry Practice Roll-Up Targets
Signal-scored acquisition targets matched to your roll-up criteria.
Most PE-backed vision care platforms consider acquiring regional optometry groups with a minimum of 5–6 locations and $3M–$5M in aggregate EBITDA. Below that threshold, you are more likely to attract a strategic acquirer — a larger regional group or an existing PE platform executing add-ons — than a sponsor seeking to establish a new platform. Building to 6–10 locations with $5M–$8M in EBITDA typically generates the most competitive interest from institutional buyers and maximizes exit valuation through a full auction process.
Yes, SBA 7(a) loans are available for individual optometry practice acquisitions up to $5M per transaction and are one of the most cost-effective financing tools for early-stage roll-up buyers. However, SBA rules prohibit using a single loan to acquire multiple practices simultaneously, so each add-on acquisition typically requires a separate SBA loan or, as the platform grows, a conventional bank credit facility or PE-backed credit line. Once the platform reaches $3M–$5M in aggregate EBITDA, lenders will typically offer senior credit facilities at 3–4x EBITDA leverage with more flexible covenant structures than SBA programs.
Patient attrition following the departure of a well-known selling OD is the single largest operational risk in optometry roll-ups. Patient loyalty in optometry is deeply personal — many patients have seen the same doctor for 10–20 years. To mitigate this, every acquisition should include a contractual transition employment agreement requiring the seller to practice on-site for at least 18–24 months post-close, actively introducing the incoming or associate OD to their patient base. Seller notes tied to 12-month and 24-month patient retention metrics further align the seller's financial interest with a smooth transition and protect the buyer from paying full price for a patient panel that erodes after close.
Insurance contract transferability is one of the most complex legal and operational issues in optometry acquisitions. Most managed vision care plans — including VSP, EyeMed, Davis Vision, and Medicaid managed care organizations — require re-credentialing of the acquiring entity and do not automatically transfer to a new legal owner. In a roll-up, this means each acquired practice must go through a credentialing process under the platform entity, which can take 60–120 days and temporarily disrupt billing. Work with a healthcare attorney experienced in vision care contracting to draft acquisition agreements that include representations about active payer contracts, and build a credentialing timeline into your integration plan for every acquisition. Avoid assuming that payer participation is guaranteed post-close without independent verification.
Several states — including California, Texas, and New York — impose corporate practice of medicine or corporate practice of optometry laws that restrict non-OD entities from directly owning or operating optometry practices. In these states, roll-up acquirers typically use a Management Services Organization structure, where the operating entity is a professional corporation owned by a licensed OD and the MSO — owned by the investor group — provides all non-clinical administrative services under a management services agreement. The MSO captures the economic value of the practice through management fees while the PC maintains clinical autonomy. This structure is well-established in healthcare M&A but requires careful legal drafting by a healthcare attorney with state-specific optometry board experience to ensure compliance and avoid fee-splitting violations.
Valuation in optometry acquisitions is primarily driven by a multiple of seller's discretionary earnings or EBITDA, typically in the range of 3–5.5x depending on practice quality. Key factors that push a practice toward the higher end of that range include high private pay and optical retail revenue mix, a patient panel of 3,000+ active patients with 70%+ recall return rates, modern diagnostic equipment, multiple ODs reducing key-person risk, and a long-term transferable lease. Practices at the lower end of the range often have heavy Medicaid or single-plan dependence, aging equipment requiring near-term replacement, or a seller who controls all patient relationships and has no associate coverage. Always conduct a quality of earnings analysis and adjust for owner add-backs before applying a multiple, and stress-test the valuation against realistic post-close patient attrition scenarios.
More Optometry Practice Guides
More Roll-Up Strategy Guides
Build your platform from the best Optometry Practice operators on the market — free to start.
Create your free accountNo credit card required
For Buyers
For Sellers